Raymond James & Associates’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-43,506
| Closed | -$846K | – | 3580 |
|
|
2018
Q1 | $846K | Buy |
43,506
+3,582
| +9% | +$69.7K | ﹤0.01% | 2252 |
|
|
2017
Q4 | $665K | Buy |
+39,924
| New | +$665K | ﹤0.01% | 2371 |
|
|
2015
Q2 | – | Sell |
-16,886
| Closed | -$791K | – | 2471 |
|
|
2015
Q1 | $791K | Sell |
16,886
-15,756
| -48% | -$738K | ﹤0.01% | 1795 |
|
|
2014
Q4 | $1.03M | Sell |
32,642
-3,189
| -9% | -$101K | 0.01% | 1553 |
|
|
2014
Q3 | $850K | Sell |
35,831
-1,039
| -3% | -$24.6K | ﹤0.01% | 1589 |
|
|
2014
Q2 | $1.11M | Buy |
36,870
+9,043
| +32% | +$271K | 0.01% | 1431 |
|
|
2014
Q1 | $735K | Buy |
27,827
+5,545
| +25% | +$146K | 0.01% | 1592 |
|
|
2013
Q4 | $560K | Buy |
22,282
+6,716
| +43% | +$169K | ﹤0.01% | 1618 |
|
|
2013
Q3 | $319K | Buy |
15,566
+1,069
| +7% | +$21.9K | ﹤0.01% | 1763 |
|
|
2013
Q2 | $289K | Buy |
+14,497
| New | +$289K | ﹤0.01% | 1714 |
|